Ashfield, part of UDG Healthcare plc, announced the launch of EmerGENE, a global end-to-end cell and gene therapy network approach which promises to support small and midsize biotechs with the commercialization of their discoveries.

A made-in-Canada life sciences company, Nimium Therapeutics, launched to develop novel therapies for patients with cardiometabolic diseases.

Interpublic Group announced today that FCB Health and McCann Health will be re-aligned under a new global network, to be called IPG Health, and a unified senior management team. In this new operating model, the distinct agency brands remain active and will continue to go to market independently, but will benefit from additional specialty services, knowledge-sharing, proactive career management, and coordinated collaboration.

MicroMass, a leading full-service health communications agency, unveiled Human Dynamics, which is a game-changing approach to help pharmaceutical brands connect with patients and create a better experience.

Biopharma company curator Flagship Pioneering, which has launched companies such as Moderna, announced a massive infusion of cash that will be used to support the development and launch of new companies taking aim at a myriad of diseases and global health threats.

Dentsu International launched dentsu health, a global solution. Drawing upon the expertise of dentsu’s global network of 2,000 health marketing experts across 85 markets in EMEA, APAC and the Americas, dentsu health is poised to become one of the top global healthcare agencies according to management.

Healthcare advertising agency PRECISIONeffect launched INFLECTIONeffect, a data-driven discipline that amplifies the uptake of medical advances.

UnitedHealthcare announced a community-based initiative, Community Catalyst, that convenes a broad range of community stakeholders to identify and address specific health care needs of members of the community and residents of publicly assisted housing who are often difficult to reach and serve.

Venture capitalist Chamath Palihapitiya is raising $800 million to finance four more special purpose acquisition companies (SPAC) that will be focused on taking biotech companies public.

Organon on June 3 celebrated the launch of the global women’s health company with employees and women from around the world, as the Organon executive leadership team rang the opening bell at the New York Stock Exchange (NYSE). Recognizing the need to listen to and act on women’s experiences to address the challenges in women’s health, Organon gathered voices from around the world to create the “Wall of Voices,” a multimedia installation outside of the NYSE.